Literature DB >> 30508378

Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.

Sara Musetti1, Leaf Huang1.   

Abstract

Nanoscience has long been lauded as a method through which tumor-associated barriers could be overcome. As successful as cancer immunotherapy has been, limitations associated with the tumor microenvironment or side effects of systemic treatment have become more apparent. In this Review, we seek to lay out the therapeutic challenges associated with the tumor microenvironment and the ways in which nanoscience is being applied to remodel the tumor microenvironment and increase the susceptibility of many cancer types to immunotherapy. We detail the nanomedicines on the cutting edge of cancer immunotherapy and how their interactions with the tumor microenvironment make them more effective than systemically administered immunotherapies.

Entities:  

Keywords:  cancer; checkpoint inhibitors; cytokines; cytotoxic T cells; immunogenic cell death; immunotherapy; nanoparticles; nanovaccine; tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 30508378     DOI: 10.1021/acsnano.8b05893

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  34 in total

1.  Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot.

Authors:  Zhaoting Li; Lianghan Zhu; Honghao Sun; Yuexin Shen; Dandan Hu; Wenhao Wu; Yixin Wang; Chenggen Qian; Minjie Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

Review 2.  Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models.

Authors:  Sayoni Maitra Roy; Vrinda Garg; Sourav Barman; Chitrita Ghosh; Amit Ranjan Maity; Surya K Ghosh
Journal:  Front Bioeng Biotechnol       Date:  2021-12-01

Review 3.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

4.  Phenylboronic ester-modified polymeric nanoparticles for promoting TRP2 peptide antigen delivery in cancer immunotherapy.

Authors:  Qiyan Wang; Zhipeng Dong; Fangning Lou; Yunxue Yin; Jiahao Zhang; Hanning Wen; Tao Lu; Yue Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 5.  Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.

Authors:  Bin Ji; Minjie Wei; Bin Yang
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 6.  Immunomodulatory Nanosystems.

Authors:  Xiangru Feng; Weiguo Xu; Zhongmin Li; Wantong Song; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2019-06-21       Impact factor: 16.806

7.  Deep exploration of random forest model boosts the interpretability of machine learning studies of complicated immune responses and lung burden of nanoparticles.

Authors:  Fubo Yu; Changhong Wei; Peng Deng; Ting Peng; Xiangang Hu
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

Review 8.  Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research.

Authors:  Balaraman Kalyanaraman
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

9.  Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention.

Authors:  Xuefei Zhou; Xiangrui Liu; Leaf Huang
Journal:  Adv Funct Mater       Date:  2020-11-10       Impact factor: 18.808

Review 10.  Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.

Authors:  Yanting Sun; Yuling Li; Shuo Shi; Chunyan Dong
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.